George Kelly Martin - Net Worth and Insider Trading
George Kelly Martin Net Worth
The estimated net worth of George Kelly Martin is at least $1 Million dollars as of 2024-11-29. George Kelly Martin is the Director of TriSalus Life Sciences Inc and owns about 247,176 shares of TriSalus Life Sciences Inc (TLSI) stock worth over $1 Million. Details can be seen in George Kelly Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Kelly Martin has not made any transactions after 2024-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of George Kelly Martin
George Kelly Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Kelly Martin owns 2 companies in total, including TriSalus Life Sciences Inc (TLSI) , and MedTech Acquisition Corp (MTAC) .
Click here to see the complete history of George Kelly Martin’s form 4 insider trades.
Insider Ownership Summary of George Kelly Martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TLSI | TriSalus Life Sciences Inc | 2024-08-28 | director |
| MTAC | MedTech Acquisition Corp | 2023-08-10 | director |
George Kelly Martin Latest Holdings Summary
George Kelly Martin currently owns a total of 1 stock. George Kelly Martin owns 247,176 shares of TriSalus Life Sciences Inc (TLSI) as of August 28, 2024, with a value of $1 Million.
Latest Holdings of George Kelly Martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences Inc | 2024-08-28 | 247,176 | 4.25 | 1,050,498 |
Holding Weightings of George Kelly Martin
George Kelly Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, George Kelly Martin has made a total of 1 transactions in TriSalus Life Sciences Inc (TLSI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TriSalus Life Sciences Inc is the sale of 9 shares on August 28, 2024, which brought George Kelly Martin around $50.
Insider Trading History of George Kelly Martin
- 1
George Kelly Martin Trading Performance
George Kelly Martin Ownership Network
George Kelly Martin Owned Company Details
What does TriSalus Life Sciences Inc do?
Who are the key executives at TriSalus Life Sciences Inc?
George Kelly Martin is the director of TriSalus Life Sciences Inc. Other key executives at TriSalus Life Sciences Inc include director & 10 percent owner Mats Wahlstrom , director & CEO and President Mary T Szela , and President & Therapeutics Jodi Devlin .
TriSalus Life Sciences Inc (TLSI) Insider Trades Summary
Over the past 18 months, George Kelly Martin made 1 insider transaction in TriSalus Life Sciences Inc (TLSI) with a net sale of 9. Other recent insider transactions involving TriSalus Life Sciences Inc (TLSI) include a net purchase of 19,815 shares made by Mary T Szela , a net purchase of 15,727 shares made by Mats Wahlstrom ,
In summary, during the past 3 months, insiders sold 0 shares of TriSalus Life Sciences Inc (TLSI) in total and bought 35,542 shares, with a net purchase of 35,542 shares. During the past 18 months, 9 shares of TriSalus Life Sciences Inc (TLSI) were sold and 35,542 shares were bought by its insiders, resulting in a net purchase of 35,533 shares.
TriSalus Life Sciences Inc (TLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.
TriSalus Life Sciences Inc Insider Transactions
George Kelly Martin Mailing Address
Above is the net worth, insider trading, and ownership report for George Kelly Martin. You might contact George Kelly Martin via mailing address: C/o Trisalus Life Sciences, Inc., 6272 W. 91st Avenue, Westminster Co 80031.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
